Population-based Assessment of Kaposi Sarcoma-associated Herpesvirus DNA in Plasma Among Ugandans

Overview

Journal J Med Virol

Specialty Microbiology

Date 2013 Jul 16

PMID 23852686

Citations 12

Authors

Fatma M Shebl

Benjamin Emmanuel

Lisa Bunts

Benon Biryahwaho

Christine Kiruthu

Meei-Li Huang

Ruth M Pfeiffer

Corey Casper

Sam M Mbulaiteye

Affiliations

Soon will be listed here.

Abstract

Risk of Kaposi sarcoma (KS) is linked to detection of Kaposi sarcoma-associated herpesvirus (KSHV) DNA in plasma, but little is known about the prevalence and risk factors for plasma KSHV DNA detection among the general population where KS is endemic. Correlates of KSHV plasma detection were investigated in a population-based sample of adult Ugandans (15-59 years) who participated in an HIV/AIDS serobehavioral survey in 2004/2005. KSHV DNA was measured in plasma of 1,080 KSHV seropositive and 356 KSHV seronegative persons using polymerase chain reaction (PCR). KSHV DNA in plasma was detected in 157 (8.7%) persons; of these 149 (95%) were KSHV seropositive and 8 (5%) were seronegative. Detection of KSHV DNA in plasma was significantly associated with male sex (P < 0.001), older age (P = 0.003), residence in a rural versus urban area (P = 0.002), geographic region (P = 0.02), and being KSHV seropositive (13.8% seropositive vs. 2.3% seronegative, P < 0.001). In a multivariable model, KSHV DNA plasma quantity was significantly higher in men (P = 0.002), inversely associated with age (P = 0.05), and residing in an urban area (P = 0.01). In Uganda, KSHV is detected more frequently in the plasma of adult males and residents of rural regions, potentially explaining the increased risk of KS in these subsets of the Ugandan population.

Citing Articles

Highly Heterogeneous Kaposi Sarcoma-Associated Herpesvirus Oral Shedding Kinetics Among People With and Without Kaposi Sarcoma and Human Immunodeficiency Virus Coinfection.

Krantz E, Mutyaba I, Nankoma J, Okuku F, Casper C, Orem J Open Forum Infect Dis. 2024; 11(10):ofae548.

PMID: 39371366 PMC: 11450676. DOI: 10.1093/ofid/ofae548.

KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine.

Casper C, Corey L, Cohen J, Damania B, Gershon A, Kaslow D NPJ Vaccines. 2022; 7(1):108.

PMID: 36127367 PMC: 9488886. DOI: 10.1038/s41541-022-00535-4.

Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections.

Sallah N, Miley W, Labo N, Carstensen T, Fatumo S, Gurdasani D Nat Commun. 2020; 11(1):3849.

PMID: 32737300 PMC: 7395761. DOI: 10.1038/s41467-020-17696-2.

Cancer Risk Studies and Priority Areas for Cancer Risk Appraisal in Uganda.

Jatho A, Tran B, Cambia J, Nanyingi M, Mugisha N Ann Glob Health. 2020; 86(1):78.

PMID: 32704483 PMC: 7350938. DOI: 10.5334/aogh.2873.

Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda.

Nalwoga A, Nakibuule M, Marshall V, Miley W, Labo N, Cose S Clin Infect Dis. 2019; 71(4):1055-1062.

PMID: 31555829 PMC: 7428384. DOI: 10.1093/cid/ciz916.

References

Mbulaiteye S, Pfeiffer R, Engels E, Marshall V, Bakaki P, Owor A . Detection of kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. J Infect Dis. 2004; 190(8):1382-6. DOI: 10.1086/424489. View

Mermin J, Musinguzi J, Opio A, Kirungi W, Ekwaru J, Hladik W . Risk factors for recent HIV infection in Uganda. JAMA. 2008; 300(5):540-9. DOI: 10.1001/jama.300.5.540. View

Shebl F, Dollard S, Pfeiffer R, Biryahwaho B, Amin M, Munuo S . Human herpesvirus 8 seropositivity among sexually active adults in Uganda. PLoS One. 2011; 6(6):e21286. PMC: 3119672. DOI: 10.1371/journal.pone.0021286. View

HUTT M . The epidemiology of Kaposi's sarcoma. Antibiot Chemother (1971). 1981; 29:3-8. DOI: 10.1159/000397432. View

Pau C, Lam L, Spira T, Black J, Stewart J, Pellett P . Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol. 1998; 36(6):1574-7. PMC: 104879. DOI: 10.1128/JCM.36.6.1574-1577.1998. View

HUTT M, BURKITT D . Geographical distribution of cancer in East Africa: a new clinicopathological approach. Br Med J. 1965; 2(5464):719-22. PMC: 1846176. DOI: 10.1136/bmj.2.5464.719. View

Mbulaiteye S, Pfeiffer R, Dolan B, Tsang V, Noh J, Mikhail N . Seroprevalence and risk factors for human herpesvirus 8 infection, rural Egypt. Emerg Infect Dis. 2008; 14(4):586-91. PMC: 2570936. DOI: 10.3201/eid1404.070935. View

Bestetti G, van Beveren M, Gessain A . Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa. J Natl Cancer Inst. 1999; 91(21):1888-9. DOI: 10.1093/jnci/91.21.1888. View

Wabinga H, Parkin D, Wabwire-Mangen F, Nambooze S . Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer. 2000; 82(9):1585-92. PMC: 2363394. DOI: 10.1054/bjoc.1999.1071. View

10.

Johnston C, Orem J, Okuku F, Kalinaki M, Saracino M, Katongole-Mbidde E . Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda. PLoS One. 2009; 4(1):e4222. PMC: 2625442. DOI: 10.1371/journal.pone.0004222. View

11.

Chang Y, Cesarman E, Pessin M, Lee F, Culpepper J, Knowles D . Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994; 266(5192):1865-9. DOI: 10.1126/science.7997879. View

12.

Fu B, Yang R, Xia F, Li B, Ouyang X, Gao S . Gender differences in Kaposi's sarcoma-associated herpesvirus infection in a population with schistosomiasis in rural China. Jpn J Infect Dis. 2012; 65(4):350-3. PMC: 3513380. DOI: 10.7883/yoken.65.350. View

13.

Biryahwaho B, Dollard S, Pfeiffer R, Shebl F, Munuo S, Amin M . Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population‐based sample in Uganda. J Infect Dis. 2010; 202(9):1347-53. PMC: 2949503. DOI: 10.1086/656525. View

14.

OETTLE A . Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Acta Unio Int Contra Cancrum. 1962; 18:330-63. View

15.

Serraino D, Toma L, Andreoni M, Butto S, Tchangmena O, Sarmati L . A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area. Eur J Epidemiol. 2002; 17(9):871-6. DOI: 10.1023/a:1015678312153. View

16.

Ronchese F . Kaposi's sarcoma; an overlooked essay of 1882. AMA Arch Derm. 1958; 77(5):542-5. DOI: 10.1001/archderm.1958.01560050050009. View

17.

Nsubuga M, Biggar R, Combs S, Marshall V, Mbisa G, Kambugu F . Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions. Cancer Lett. 2008; 263(2):182-8. PMC: 2440724. DOI: 10.1016/j.canlet.2007.12.025. View

18.

Rabkin C, Schulz T, Whitby D, Lennette E, Magpantay L, Chatlynne L . Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis. 1998; 178(2):304-9. DOI: 10.1086/515649. View

19.

Mbulaiteye S, Atkinson J, Whitby D, Wohl D, Gallant J, Royal S . Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study. J Clin Virol. 2006; 35(4):442-9. DOI: 10.1016/j.jcv.2005.10.010. View

20.

. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California. MMWR Morb Mortal Wkly Rep. 1981; 30(25):305-8. View